Search results

Page results

• First participant joins new Parkinson’s Disease study at UCLH

  UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.

• Patient-initiated follow-up (PIFU) for women with endometrial cancer

  This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.

• Research at UCLH to tackle RSV infections in infants

  UCLH will play a vital role in a new respiratory virus study.

• Charity at UCLH

  Information about our UCLH Charity, charity funds and associated charities.

• COVID-19 research studies rapidly opened at UCLH

  Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.

• Having surgery at UCLH

  Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.

• Why is it important to get your heart checked? Information for patients with mitochondrial disease

  This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.

• Plasma Exchange Service at NHNN

  Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.

• Climate action and sustainability

  UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.

• 1,000 RSV vaccines administered at UCLH

  UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.